| 英文名称 |
中文名称 |
CAS号 |
操作 |
| BAY-57-1293 |
普瑞利韦 |
348086-71-5 |
详细
|
| MI-503 |
MI-503 |
1857417-13-0 |
详细
|
| MK-8722 |
MK-8722 |
1394371-71-1 |
详细
|
| 2'3'-cGAMP |
2,3-CGAMP |
1441190-66-4 |
详细
|
| (S)-PF-06873600 |
(S)-PF-06873600 |
2185859-59-8 |
详细
|
| VH-032 |
VH-032 |
1448188-62-2 |
详细
|
| TAS4464 |
TAS4464 |
1848959-10-3 |
详细
|
| Uridine 5'-Diphosphoglucose Disodium Salt |
二磷酸尿苷葡萄糖二钠盐 |
28053-08-9 |
详细
|
| IPN-60090 |
IPN-60090 |
1853164-83-6 |
详细
|
| NSC-706744 |
LMP744; LMP-744; LMP 744; MJ-III-65; NSC-706744 |
308246-57-3 |
详细
|
| EPZ031686 |
CS-2707 |
1808011-22-4 |
详细
|
| Inarigivirsoproxil |
INARIGIVIR SOPROXIL |
942123-43-5 |
详细
|
| Mdivi-1 |
3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮 |
338967-87-6 |
详细
|
| PF-06873600 |
PF-06873600 |
2185857-97-8 |
详细
|
| GDC-0941 |
GDC-0941 |
957054-30-7 |
详细
|
| CF102 |
2-CL-IB-MECA |
163042-96-4 |
详细
|
| Tavaborole |
他伐硼罗 |
174671-46-6 |
详细
|
| JHU37160 |
化合物JHU 37160 |
2369979-68-8 |
详细
|
| Ozanimod |
奥扎莫德 |
1306760-87-1 |
详细
|
| ZZW-115 hydrochloride |
ZZW-115 hydrochloride |
10122-45-9 |
详细
|
| BCI |
BCI |
1245792-51-1 |
详细
|
| LoMitapide Mesylate |
甲磺酸洛美他派 |
202914-84-9 |
详细
|
| LoMitapide |
洛美他派 |
182431-12-5 |
详细
|
| PXD-101 |
贝利司他 |
866323-14-0 |
详细
|
| INCB-024360 |
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914471-09-3 |
详细
|
| Lesinurad |
雷西那德 |
878672-00-5 |
详细
|
| ASP-2215 (GILTERITINIB) |
吉列替尼 |
1254053-43-4 |
详细
|
| NU-9056 |
NU 9056 |
1450644-28-6 |
详细
|
| SEP-0372814 |
3-Methyl-2-((1S,2S)-2-(quinolin-2-yl)cyclopropyl)-3H-iMidazo[4,5-f]quinoline |
1516896-09-5 |
详细
|
| PST2744 |
PST-2744 |
203737-93-3 |
详细
|
| SCR-1438 |
4-(4-amino-2-fluorophenoxy)-3-chloro-N-(diphenylmethylene)-2-Pyridinamine |
1174046-76-4 |
详细
|
| PST2238 |
ROSTAFUROXIN |
156722-18-8 |
详细
|
| PST2286 |
PST2286 |
26629-41-4 |
详细
|
| KPT9274 |
KPT-9274 |
1643913-93-2 |
详细
|
| TP-2857 |
TP-2857 |
1575491-01-8 |
详细
|
| AVITINIB |
N-(3-((2-((3-氟-4-(4-甲基哌嗪-1-基)苯基)氨基)-7H-吡咯并[2,3-D]嘧啶-4-基)氧基)苯基)丙烯酰胺酸盐 |
1557268-88-8 |
详细
|
| CPFX4158 |
CPFX4158 |
1804962-84-2 |
详细
|
| TP808 |
TP808 |
852821-06-8 |
详细
|
| BMS-794833 |
BMS-794833 |
1174046-72-0 |
详细
|
| SAR191801 |
化合物HPGDS-IN-1 |
1234708-04-3 |
详细
|
| RX-518 |
RX-518 |
1660963-42-7 |
详细
|
| SAR348830 |
(7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol |
1462949-64-9 |
详细
|
| CXD101 |
CXD-101 |
934828-12-3 |
详细
|
| CBP-307 |
[CBP-307] |
|
详细
|
| TBA-354 |
TBA-354 |
1257426-19-9 |
详细
|
| DBPR211 |
1-(2,4-二氯苯基)-N-1-哌啶基-4-[[(1-吡咯烷基磺酰基)氨基]甲基]-5-[5-[2-[4-(三氟甲基)苯基]乙炔基]-2-噻吩基]-1H-吡唑-3-甲酰胺 |
1429239-98-4 |
详细
|
| EPZ-6438 |
EPZ-6438 |
1403254-99-8 |
详细
|
| M4205 |
化合物M4205 |
2590556-80-0 |
详细
|
| X-376 |
恩沙替尼 |
1365267-27-1 |
详细
|
| GNE7915 |
GNE7915 |
1351761-44-8 |
详细
|
| NG25 |
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺 |
1315355-93-1 |
详细
|
| GSK 1070916 |
GSK1070916 |
942918-07-2 |
详细
|
| ACY-738 |
N-羟基-2-[(1-苯基环丙基)氨基]-5-嘧啶甲酰胺 |
1375465-91-0 |
详细
|
| S-22611 |
PVM/MA共聚物 |
1644545-52-7 |
详细
|
| Enasidenib (AG-221) |
恩西地平 |
1446502-11-9 |
详细
|
| Mitapivat |
PKR-IN-1 |
1260075-17-9 |
详细
|
| AZD-1390 |
CS-2816 |
2089288-03-7 |
详细
|
| RGFP966 |
(2E)-N-(2-氨基-4-氟苯基)-3-[1-(3-苯基-2-丙烯-1-基)-1H-吡唑-4-基]-2-丙烯酰胺 |
1396841-57-8 |
详细
|
| AST487 |
AST 487 |
630124-46-8 |
详细
|
| Venadaparib |
Venadaparib |
1681017-83-3 |
详细
|
| A8301 |
3-(6-甲基-2-吡啶基)-N-苯基-4-(4-喹啉基)-1H-吡唑-1-硫代甲酰胺 |
909910-43-6 |
详细
|
| PND-1186 |
PND1186 |
1061353-68-1 |
详细
|
| Vafidemstat(ORY-2001) |
VAFIDEMSTAT |
1357362-02-7 |
详细
|
| HM43239 |
化合物HM43239 |
2569527-64-4 |
详细
|
| AZD-8055 |
AZD8055 |
1009298-09-2 |
详细
|
| GZD824 |
GZD824 |
1257628-77-5 |
详细
|
| GZD824 |
GZD824DIMESYLATE |
1421783-64-3 |
详细
|
| BGB3111 |
(±)-赞鲁替尼 |
1633350-06-7 |
详细
|
| ABT-263 |
ABT 263 |
923564-51-6 |
详细
|
| BAY-1217389 |
CS-2361 |
1554458-53-5 |
详细
|
| PCO371 |
PCO371 |
1613373-33-3 |
详细
|
| CFI-402257 |
CS-2627 |
1610759-22-2 |
详细
|
| GSK 561679A |
3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺 |
885220-61-1 |
详细
|
| RTA-408 |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
详细
|
| EW-7197 |
EW-7197 |
1352608-82-2 |
详细
|
| BGB-324; R428 |
R428 |
1037624-75-1 |
详细
|
| gSK-461364 |
GSK461364 |
929095-18-1 |
详细
|
| ARS 1620 |
CPD1588 |
1698055-85-4 |
详细
|
| IDO inhibitor 1 |
4-[[2-[(氨基磺酰基)氨基]乙基]氨基]-N'-(3-溴-4-氟苯基)-N-羟基-1,2,5-恶二唑-3-甲脒 |
1204669-37-3 |
详细
|
| Tosedostat |
托舍多特 |
238750-77-1 |
详细
|
| AZD6738 |
AZD6738 |
1352226-88-0 |
详细
|
| CPI-444 |
CPI-444 |
1202402-40-1 |
详细
|
| IDO inhibitor 1 |
艾卡哚司他 |
1204669-58-8 |
详细
|
| MLN-2480 |
MLN2480 |
1096708-71-2 |
详细
|
| AZD-0364 |
CS-2696 |
2097416-76-5 |
详细
|
| L-685 458 |
CS-2367 |
292632-98-5 |
详细
|
| 3-deazaneplanocin A |
3-去氮腺嘌呤A |
120964-45-6 |
详细
|
| Refametinib |
瑞法替尼 |
923032-37-5 |
详细
|
| MLN4924 |
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯 |
905579-51-3 |
详细
|
| LOXO195 |
LOXO195 |
1350884-56-8 |
详细
|
| 3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-7-CARBOXYLIC ACID |
3-氧代-3,4-二氢-2H-1,4-苯并恶嗪-7-羧酸 |
214848-62-1 |
详细
|
| 6-iodo-[1,2,4]triazolo[1,5-a]pyridine |
6-碘-[1,2,4]三唑并[1,5-A]吡啶 |
614750-84-4 |
详细
|
| (S)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-amine |
CPD3615-A5 |
2045894-03-7 |
详细
|
| 2,5-Dichloro-4-iodopyridine |
2,5-二氯-4-碘吡啶 |
796851-03-1 |
详细
|
| VX809 |
鲁玛卡托 |
936727-05-8 |
详细
|
| LDE-225 (SONIDEGIB) |
索尼吉布 |
956697-53-3 |
详细
|
| Amonafide |
氨萘非特 |
69408-81-7 |
详细
|
| Mitonafide |
米托萘胺 |
54824-17-8 |
详细
|
| LOXO-195 |
LOXO-195 |
2097002-61-2 |
详细
|
| Ivosidenib |
艾伏尼布 |
1448347-49-6 |
详细
|